Details for Patent: 9,688,711

Which drugs does patent 9,688,711 protect, and when does it expire?

Patent 9,688,711 protects ZEMDRI and is included in one NDA.

This patent has twenty-eight patent family members in twenty-one countries.

Summary for Patent: 9,688,711

Title:	Antibacterial aminoglycoside analogs
Abstract:	Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): ##STR00001## including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q.sub.1, Q.sub.2, Q.sub.3, R.sub.8 and R.sub.9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Inventor(s):	Aggen; James Bradley (Burlingame, CA), Goldblum; Adam Aaron (Berkeley, CA), Linsell; Martin Sheringham (San Mateo, CA), Dozzo; Paola (San Francisco, CA), Moser; Heinz Ernst (San Mateo, CA), Hildebrandt; Darin James (Cupertino, CA), Gliedt; Micah James (Sunnyvale, CA)
Assignee:	Achaogen, Inc. (South San Francisco, CA)
Application Number:	15/001,797
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,688,711
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 9,688,711

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cipla Usa	ZEMDRI	plazomicin sulfate	SOLUTION;INTRAVENOUS	210303-001	Jun 25, 2018		RX	Yes	Yes				Y		METHOD OF USING PLAZOMICIN TO TREAT BACTERIAL INFECTIONS

International Family Members for US Patent 9,688,711

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008326297
Brazil	PI0819319
Canada	2706369
China	101868472